rs2071421

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000487.6(ARSA):​c.1055A>G​(p.Asn352Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.143 in 1,576,320 control chromosomes in the GnomAD database, including 18,971 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign,other (★★).

Frequency

Genomes: 𝑓 0.19 ( 3436 hom., cov: 34)
Exomes 𝑓: 0.14 ( 15535 hom. )

Consequence

ARSA
NM_000487.6 missense

Scores

4
12

Clinical Significance

Benign/Likely benign; other criteria provided, multiple submitters, no conflicts U:1B:15O:3

Conservation

PhyloP100: 1.46
Variant links:
Genes affected
ARSA (HGNC:713): (arylsulfatase A) The protein encoded by this gene hydrolyzes cerebroside sulfate to cerebroside and sulfate. Defects in this gene lead to metachromatic leucodystrophy (MLD), a progressive demyelination disease which results in a variety of neurological symptoms and ultimately death. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0014927089).
BP6
Variant 22-50625988-T-C is Benign according to our data. Variant chr22-50625988-T-C is described in ClinVar as [Likely_benign, other]. Clinvar id is 3050.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-50625988-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.324 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ARSANM_000487.6 linkuse as main transcriptc.1055A>G p.Asn352Ser missense_variant 6/8 ENST00000216124.10 NP_000478.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ARSAENST00000216124.10 linkuse as main transcriptc.1055A>G p.Asn352Ser missense_variant 6/81 NM_000487.6 ENSP00000216124 P1

Frequencies

GnomAD3 genomes
AF:
0.192
AC:
29196
AN:
152016
Hom.:
3416
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.329
Gnomad AMI
AF:
0.181
Gnomad AMR
AF:
0.240
Gnomad ASJ
AF:
0.138
Gnomad EAS
AF:
0.164
Gnomad SAS
AF:
0.145
Gnomad FIN
AF:
0.0660
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.126
Gnomad OTH
AF:
0.187
GnomAD3 exomes
AF:
0.165
AC:
31196
AN:
188538
Hom.:
3261
AF XY:
0.158
AC XY:
15952
AN XY:
100644
show subpopulations
Gnomad AFR exome
AF:
0.337
Gnomad AMR exome
AF:
0.298
Gnomad ASJ exome
AF:
0.141
Gnomad EAS exome
AF:
0.173
Gnomad SAS exome
AF:
0.148
Gnomad FIN exome
AF:
0.0631
Gnomad NFE exome
AF:
0.127
Gnomad OTH exome
AF:
0.158
GnomAD4 exome
AF:
0.138
AC:
196120
AN:
1424186
Hom.:
15535
Cov.:
37
AF XY:
0.137
AC XY:
96518
AN XY:
704492
show subpopulations
Gnomad4 AFR exome
AF:
0.351
Gnomad4 AMR exome
AF:
0.294
Gnomad4 ASJ exome
AF:
0.139
Gnomad4 EAS exome
AF:
0.164
Gnomad4 SAS exome
AF:
0.147
Gnomad4 FIN exome
AF:
0.0646
Gnomad4 NFE exome
AF:
0.127
Gnomad4 OTH exome
AF:
0.147
GnomAD4 genome
AF:
0.192
AC:
29259
AN:
152134
Hom.:
3436
Cov.:
34
AF XY:
0.188
AC XY:
14013
AN XY:
74368
show subpopulations
Gnomad4 AFR
AF:
0.329
Gnomad4 AMR
AF:
0.240
Gnomad4 ASJ
AF:
0.138
Gnomad4 EAS
AF:
0.164
Gnomad4 SAS
AF:
0.146
Gnomad4 FIN
AF:
0.0660
Gnomad4 NFE
AF:
0.126
Gnomad4 OTH
AF:
0.192
Alfa
AF:
0.144
Hom.:
3233
Bravo
AF:
0.215
TwinsUK
AF:
0.138
AC:
510
ALSPAC
AF:
0.119
AC:
458
ESP6500AA
AF:
0.299
AC:
1305
ESP6500EA
AF:
0.123
AC:
1050
ExAC
AF:
0.132
AC:
15352
Asia WGS
AF:
0.195
AC:
680
AN:
3478

ClinVar

Significance: Benign/Likely benign; other
Submissions summary: Uncertain:1Benign:15Other:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Metachromatic leukodystrophy Benign:6Other:2
Benign, no assertion criteria providedclinical testingNatera, Inc.Dec 10, 2019- -
not provided, no classification providedliterature onlyGeneReviews-- -
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submittercurationSIB Swiss Institute of BioinformaticsOct 15, 2018This variant is interpreted as Benign - Stand Alone, for Metachromatic leukodystrophy, autosomal recessive. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. BP4 => Multiple lines of computational evidence suggest no impact on gene or gene product (conservation, evolutionary, splicing impact, etc.). BS3 => Well-established in vitro or in vivo functional studies show no damaging effect on protein function or splicing (https://www.ncbi.nlm.nih.gov/pubmed/11941485) (https://www.ncbi.nlm.nih.gov/pubmed/2574462). -
not provided, no classification providedin vitroGelb Laboratory, University of Washington-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJun 10, 2021- -
not specified Benign:5
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
not provided Benign:3Other:1
other, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 24, 2018- Variant classified as "other reportable" ??? variant is clinically benign (not associated with disease) but is reported when observed (e.g. pseudodeficiency alleles).
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsOct 11, 2016- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 11, 2021This variant is associated with the following publications: (PMID: 2574462, 21648305, 8897113, 30026549, 32437521, 26577183, 31670782, 32470555, 31312839, 31694723, 23581857) -
Metachromatic leukodystrophy, juvenile type Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-ClinVar reports this variant as a Pseudodeficiency allele from ClinVar. Homozygosity for the p.Asn350Ser variant alone results in 50% or more of the mean control ARSA enzyme activity in leukocytes. Allele frequency is common in at least one population database (frequency: 39.478% in ExAC) based on the frequency threshold of 1.151% for this gene.Variant was observed in a homozygous state in population databases more than expected for disease.This variant is interpreted as Benign - Stand Alone, for Metachromatic leukodystrophy, autosomal recessive. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. BP4 => Multiple lines of computational evidence suggest no impact on gene or gene product (conservation, evolutionary, splicing impact, etc.). BS3 => Well-established in vitro or in vivo functional studies show no damaging effect on protein function or splicing (https://www.ncbi.nlm.nih.gov/pubmed/11941485) (https://www.ncbi.nlm.nih.gov/pubmed/2574462). (ClinVar: SIB Swiss Institute of Bioinformatics) -
ARYLSULFATASE A POLYMORPHISM Benign:1
Benign, no assertion criteria providedliterature onlyOMIMDec 01, 1997- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Uncertain
-0.080
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.30
T;T;T;.;T
Eigen
Benign
-0.088
Eigen_PC
Benign
0.082
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.87
.;.;.;D;D
MetaRNN
Benign
0.0015
T;T;T;T;T
MetaSVM
Benign
-1.2
T
MutationTaster
Benign
0.034
P;P;P;P;P;P;P
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.2
N;N;N;N;N
REVEL
Benign
0.26
Sift
Benign
0.23
T;T;T;T;T
Sift4G
Benign
0.28
T;T;T;T;T
Vest4
0.15
ClinPred
0.011
T
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.46

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2071421; hg19: chr22-51064416; COSMIC: COSV53349851; COSMIC: COSV53349851; API